Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
03/22/2001 | CA2384920A1 Moraxella catarrhalis antigen, corresponding gene and uses thereof |
03/22/2001 | CA2384749A1 Novel human proteins, polynucleotides encoding them and methods of using the same |
03/22/2001 | CA2384324A1 Proteins associated with cell differentiation |
03/22/2001 | CA2384294A1 Nicotinic acetylcholine receptor: alpha10 subunit |
03/22/2001 | CA2384135A1 Dipeptidyl peptidases |
03/22/2001 | CA2384081A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
03/22/2001 | CA2383927A1 Protein phosphatase and kinase proteins |
03/22/2001 | CA2383831A1 Method for increasing the yield of recombinant proteins in microbial fermentation processes |
03/22/2001 | CA2383402A1 Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions |
03/22/2001 | CA2383217A1 Lysosomal targeting pathway enzymes |
03/22/2001 | CA2383177A1 Human g-protein coupled receptor |
03/22/2001 | CA2383081A1 Polypeptides from moraxella (branhamella) catarrhalis |
03/22/2001 | CA2382067A1 Recombinant microorganisms |
03/22/2001 | CA2381347A1 Regulatory sequences and expression cassettes for yeasts |
03/22/2001 | CA2381066A1 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications |
03/22/2001 | CA2379541A1 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
03/22/2001 | CA2350823A1 Thermostable luciferases from photuris pennsylvanica and pyrophorus plagiophthalamus and methods of production |
03/21/2001 | EP1085098A2 A composition for providing long term stability to cells for diagnostic testing |
03/21/2001 | EP1085096A2 Preparation of high trehalose content product |
03/21/2001 | EP1085095A1 Synthesis of optically active phenylalanine analogs through microbial transformations |
03/21/2001 | EP1085094A2 Nucleotide sequences which code for the dapF gene |
03/21/2001 | EP1085093A2 Genes and polynucleotides associated with ultraviolet radiation-mediated skin damage and uses thereof |
03/21/2001 | EP1085092A1 Phosphodiesterase enzymes |
03/21/2001 | EP1085091A1 Nucleotide sequences coding for thrE-gene and process for the fermentative preparation of L-threonine using coryneform bacteria |
03/21/2001 | EP1085089A2 Human cyclic nucleotide phosphodiesterase |
03/21/2001 | EP1085087A2 Method for producing amino acids by fermentation using aminoquinoline resistant bacterial strains |
03/21/2001 | EP1085086A2 Method for producing amino acids by fermentation using DNA gyrase inhibitor resistant bacterial strains |
03/21/2001 | EP1084709A1 Oral recombinant lactobacilli vaccines |
03/21/2001 | EP1084272A1 Heteroduplex mutational vectors and use thereof in bacteria |
03/21/2001 | EP1084268A1 Biotechnological production of polyglutaminic acid |
03/21/2001 | EP1084267A1 Vitamin c production in microorganisms and plants |
03/21/2001 | EP1084262A1 Promoter and constructions for expression of recombinant proteins in filamentous fungi |
03/21/2001 | EP1084258A1 Industrial method for producing heterologous proteins in e.coli and strains useful for said method |
03/21/2001 | EP1084257A1 A STRAIN E.COLI JM83/pKP2 TRANSFORMED WITH A NOVEL PLASMID AND PHYTASE PRODUCED THEREFROM |
03/21/2001 | EP1084256A2 Acyl coa:cholesterol acyltransferase related nucleic acid sequences |
03/21/2001 | EP1084250A2 Enzyme |
03/21/2001 | EP1084248A2 Novel insulin analogs with enhanced zinc binding |
03/21/2001 | EP1084241A1 G-protein coupled receptor, named 2871 receptor |
03/21/2001 | EP1084239A1 Polymorphic markers of prostate carcinoma tumor antigen-1 (pcta-1) |
03/21/2001 | EP1084235A1 Human protein c polypeptide |
03/21/2001 | EP1084231A1 Transformed cell lines which express heterologous g-protein-coupled receptors |
03/21/2001 | EP1084142A1 Gpr35a receptor |
03/21/2001 | EP1084141A1 nrdF |
03/21/2001 | EP1084135A1 The human kidney specific gene kk86 |
03/21/2001 | EP1083984A1 Method for populating substrates with biological cells and populating devices that can be used therefor |
03/21/2001 | EP1083934A2 Gene therapy method |
03/21/2001 | EP1083927A1 HUMAN MINOR VAULT PROTEIN p193 |
03/21/2001 | EP1083923A1 Acrp30r1: a homolog of acrp30 (30 kd adipocyte complement-related protein) |
03/21/2001 | EP1083910A1 nrdE |
03/21/2001 | EP1083909A1 hCEPR RECEPTOR |
03/21/2001 | CN1288061A Method for prepn. of D-pantothenic acid using bar shaped bacteria fermentation |
03/21/2001 | CN1288060A Reproduced freely particles in bar shaped bacteria |
03/21/2001 | CN1288058A Novel nucleotide series with coded pgi gene |
03/21/2001 | CN1288055A Novel nucleotide series with coded dapF gene |
03/21/2001 | CN1288054A Commercial prodn. mehtod for producing silkworm chrysalis Chinese caterpillar fungus |
03/21/2001 | CN1063488C DNA amplification |
03/21/2001 | CN1063483C High-butanol ratio clostridium acetobutylicium and culturing method and use thereof |
03/20/2001 | US6204435 Nucleotide sequences which code insect poison; for biological pest control |
03/20/2001 | US6204377 Kojibiose phosphorylase glucosyl-saccharides produced by transglycosylation |
03/20/2001 | US6204375 Preserving ribonucleic acids in cell; incubate cells with blocking agent, the blocker infiltrates the cell and prevents ribonucleic acid degradation in cells |
03/20/2001 | US6204371 Compositions and methods for the treatment and diagnosis of immune disorders |
03/20/2001 | US6204366 Specific binding agents |
03/20/2001 | US6204359 Form of amphiregulin, methods for producing and using the same and compositions comprising the same |
03/20/2001 | US6204057 Polynucleotides and the proteins encoded thereby, suitable for controlling lamellicorn beetles |
03/20/2001 | US6204056 Micropathological patient replica based on unadulterated whole blood |
03/20/2001 | US6204049 Fungal compositions for bioremediation |
03/20/2001 | US6204048 Pure culture of mutant microorganism pseudomonas; dinitrification of fuels |
03/20/2001 | US6204045 Genetically engineered infectious laryngotracheitis virus; for the development of vaccines against viral disease |
03/20/2001 | US6204042 Isolated polynucleotide segment |
03/20/2001 | US6204041 Deregulation of glutamine PRPP amidotransferase activity |
03/20/2001 | US6204040 Nucleotide sequence coding oxidoreductase; for use in sorbose fermentation |
03/20/2001 | US6204039 Nucleotide sequences coding enzymatic polypeptide; for use in the design and detection of herbicides |
03/20/2001 | US6204038 Desaturase antigen of Mycobacterium tuberculosis |
03/20/2001 | US6204032 Method for producing pravastatin precursor, ML-236B |
03/20/2001 | US6204022 Low-toxicity human interferon-alpha analogs |
03/20/2001 | US6204021 Amino acid and nucleotide sequences; hybridization probes; recombinant production; diagnosis, prevention, and treatment of nervous system disorders; anticarcinogenic agents; antiinflammatory/antifertility agents; immunosuppressants |
03/20/2001 | US6204020 DNA encoding N∇2 CSF-1 (short form) and carboxy truncated fragment thereof |
03/20/2001 | US6204013 Nucleotide sequence of myocardium secreted protein-5; recombinant production; drug screening; therapy of congestive heart failure; probes; primers; antibodies |
03/20/2001 | US6204011 Human receptor tyrosine kinase, KDR |
03/20/2001 | US6204006 Microbial strains producing sphingolipid bases |
03/20/2001 | US6203996 Rapid detection of bacteria liquid cultures |
03/20/2001 | US6203995 Agouti-related transcript antibodies and methods of use |
03/20/2001 | US6203986 Visualization of RNA in living cells |
03/20/2001 | US6203979 Polynucleotide which codes for protein of defined amino acid sequences; diagnosis, prevention, and therapy of cell proliferative and immune disorders; anticarcinogenic agents; antiproliferative/antiarthritic agents; crohn's disease |
03/20/2001 | US6203811 Termite control compositions |
03/20/2001 | US6203801 Coccidiosis polypeptide and vaccines |
03/20/2001 | US6203800 Screening for antibacterial agents; genetic engineering |
03/20/2001 | CA2318519A1 Genes and polypeptides associated with ultraviolet radiation-mediated skin damage and uses thereof |
03/20/2001 | CA2098303C Synthetic bioadhesive polypeptide |
03/20/2001 | CA2048056C Microorganisms and their use in delicatessen products |
03/15/2001 | WO2001018547A1 Essential genes and assays relating thereto |
03/15/2001 | WO2001018264A1 Improved bacterial oxidation of sulphide ores and concentrates |
03/15/2001 | WO2001018232A2 Drug target isogenes: polymorphisms in the uncoupling protein 3 (mitochondrial, proton carrier) gene |
03/15/2001 | WO2001018226A1 Method for producing exopolysaccharides |
03/15/2001 | WO2001018222A1 Methods and compositions for the chromosomal integration of heterologous sequences |
03/15/2001 | WO2001018219A1 Regulatory sequences functioning in filamentous fungi |
03/15/2001 | WO2001018218A1 Expression of proteins in genetically modified fungi |
03/15/2001 | WO2001018217A2 Thermus promoters for gene expression |
03/15/2001 | WO2001018216A2 26176, a novel calpain protease and uses thereof |
03/15/2001 | WO2001018215A1 Method for producing active serine proteases and inactive variants |